Product Reports Resources Pricing Login Book a demo

Cellanome

Biotech & Life Sciences · Foster City, United States · Founded 2020

Cellanome is a cutting-edge startup focused on revolutionizing the field of cell biology through its innovative automated platform. The company’s technology allows researchers to gain a deeper understanding of individual cell behaviors, interactions, and functions across a variety of conditions and parameters. This is achieved on a massive scale, enabling the study of numerous cells simultaneously. The primary clients for Cellanome are researchers and professionals in the life sciences and medical fields. These clients benefit from the platform’s ability to perform live cell phenotypic and functional assays iteratively. This means that researchers can observe how cells react to different stimuli over time, providing a detailed view of cellular responses. Unlike traditional methods that often measure bulk responses, Cellanome’s platform highlights the unique reactions of individual cells, offering a more granular and precise analysis. Operating in the biotechnology and life sciences market, Cellanome’s business model revolves around providing its platform as a service to research institutions, pharmaceutical companies, and biotech firms. The company generates revenue by offering subscriptions or licensing its technology, as well as through potential collaborations and partnerships with other entities in the field. The platform is designed to integrate seamlessly into existing cell biology workflows, which means it can be easily adopted by labs without the need for significant changes to their current processes. This flexibility allows researchers to modify or create new live cell assays, making the platform a versatile tool in various experimental setups. In summary, Cellanome is at the forefront of cell biology innovation, providing a powerful tool for researchers to explore cellular behaviors in unprecedented detail. The company’s focus on scalability and precision makes it a valuable asset in the life sciences and medical research communities. Keywords: automated platform, cell biology, live cell assays, phenotypic analysis, functional assays, life sciences, medical research, biotechnology, cellular interactions, research innovation.

Investors

3 investors on Cellanome's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Synetro Group
DCVC
8VC

Global footprint

Where Cellanome has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States95.8%
🇸🇬 Singapore2.1%
🇬🇧 United Kingdom1.1%
🇰🇷 South Korea1.1%
4 countries shown

Talent graph

The shape of Cellanome's talent

Dealroom maps Cellanome's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

5 team members profilednamed & role-tagged by Dealroom
123 employeestotal headcount
2 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Cellanome's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Cellanome

An AI-synthesized read of the highest-engagement posts about Cellanome on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cellanome on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.